Abstract:The effects of N-methyl-D-aspartate (NMDA), kainate, S-alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) and KCl on striatal nitric oxide (NO), acetylcholine (ACh), dopamine (DA), serotonin (5-HT), aspartate (ASP), glutamate (GLU) and gamma-aminobutyric acid (GABA) release were measured in anaesthetized rats in vivo by microdialysis and in vitro in organotypic slice cultures. Local NMDA (1-100 mu M) infusion by retrodialysis dose-dependently increased levels of classical transmitters, NO2-, NO3-, citrulline and arginine at similar thresholds (10 mu M) Similar patterns of NMDA-evoked (50 mu M) release were seen in striatal cultures. NMDA-evoked changes were all calcium-dependent and blocked by NMDA (APV or MK-801) but not AMPA/kainate (DNQX) receptor antagonists, excepting DA which could be prevented by both. In vivo, kainate increased NO2-, NO3-, CIT and ARG levels at 50 and 100 mu M but was less potent than NMDA. Kainate also evoked significant ACh, DA and GLU release dose-dependently starting at 1-10 mu M whereas 5-HT, ASP and GABA required 50 or 100 mu M doses. Kainate effects were inhibited by DNQX, but not by APV, and were calcium-dependent. AMPA failed to alter NO2-, NO3-, CIT or ARG levels at 50 or 100 mu M doses but dose-dependently increased ACh and DA. Similar results were seen with kainate (50 mu M) and AMPA (50 mu M) in vitro. KCI evoked NO2-, NO3-, CIT and ARG release as well as that of the classical transmitters in vivo and in vitro. In vivo administration of the NO synthase inhibitor L-nitroarginine (L-NARG; 100 mu M) significantly reduced NO2-, NO3- and CIT levels and prevented NMDA, kainate or KCI-evoked increases. It also potentiated ACh, ASP, GLU and GABA release and reduced that of DA in response to 50 mu M NMDA whereas treatment with an NO-donor (SNAP; 10 mu M) significantly reduced evoked ACh, ASP and GLU release. The NO synthase inhibitor L-NARG potentiated kainate-evoked ACh release and reduced that of DA, although less potently than NMDA, but it had no effect on KCI-evoked transmitter release. Overall, these results show that both NMDA and kainate increase striatal NO release at similar dose-thresholds as for classical transmitter release suggesting that NO is dynamically released under physiological and not just pathological conditions. Reduction of striatal NO levels also potentiates calcium-dependent transmitter release in response to NMDA and, to a lesser extent, kainate, whereas increasing them reduces it. This is consistent with a role for NO as a neuroprotective agent in this region acting to desensitize NMDA receptors.

The inhibition of nitric oxide synthase enhances PSA-NCAM expression and CREB phosphorylation in the rat hippocampus

THE INHIBITIVE EFFECT OF NITRIC OXIDE ON HIPPOCAMPAL NEURONS EXCITATION

In vivo Detection of Nitric Oxide in Rat Hippocampus

Effects of L-arginine and Nω-nitro-L-arginine Methylester on Learning and Memory and Α7 Nachr Expression in the Prefrontal Cortex and Hippocampus of Rats

Effects of intrahippocampal l-NAME treatment on the behavioral long-term potentiation in dentate gyrus

The Pathway-Selective Dependence of Nitric Oxide for Long-Term Potentiation in the Anterior Cingulate Cortex of Adult Mice

Aging Patterns of Neuronal Nitric Oxide Synthase in Hippocampus of Senescence Accelerated Mouse

Reduced Neuronal Nitric Oxide Synthase is Involved in Ischemia‐induced Hippocampal Neurogenesis by Up‐regulating Inducible Nitric Oxide Synthase Expression

Effect of NG-nitro-L-arginine methyl ester on the spatial learning and memory function and expression of inducible nitric oxide synthase in hippocampus in rats with chronic cerebral ischemia

A nitric oxide synthase inhibitor, L-NAME, prevents L-arginine-induced downregulation of the rat cortical somatostatinergic system

Real-time measurement of murine hippocampus NO levels in response to cerebral ischemia/reperfusion.

Spatial Learning and Memory Induce Up-Regulation of Nitric Oxide-Producing Neurons in Rat Brain

Inhibition of Nitric Oxide-Induced Nuclear Localization of Capon by Nmda Receptor Antagonist in Cultured Rat Primary Astrocytes

Nitric oxide impairs spatial learning and memory in a rat model of Alzheimer’s disease via disturbance of glutamate response in the hippocampal dentate gyrus during spatial learning

Physiological Control of Nitric Oxide in Neuronal BACE1 Translation by Heme-Regulated eIF2α Kinase HRI Induces Synaptogenesis

Photolytic release of nitric oxide modulates NMDA receptor-mediated transmission but does not induce long-term potentiation at hippocampal synapses

Impaired effect of L-NA on the learning and memory abilities of rats models and correlative analysis of NO and SS

Peroxynitrite Donor Impairs Excitability of Hippocampal Ca1 Neurons by Inhibiting Voltage-Gated Sodium Currents Via Cgmp Pathway

NMDA and kainate-evoked release of nitric oxide and classical transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role.

Nitrergic modulation of neuronal excitability in the mouse hippocampus is mediated via regulation of Kv2 and voltage‐gated sodium channels

The Influence of L-NNA on GFAP Immunoreactivity in Hippocampus